 |
|||||||||
|
|
Barbara Hales received her M.Sc. in Pharmacognosy from the Philadelphia College of Pharmacy and Science and her Ph.D. in Pharmacology from McGill University. She was awarded an FRSQ postdoctoral fellowship and then she took up an appointment at McGill University in 1979 where she has remained to the present. Dr. Hales’ research interests focus on mechanisms of action of drugs as teratogens. She studies developmental toxicity using a combination of in vivo, in vitro, and molecular approaches with the goal of elucidating how the embryo responds to insult after direct or maternal exposure and the consequences to progeny of paternal drug exposure.
|